Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with ...
"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...
Morning Overview on MSN
Single dose of potent psychedelic slashes depression in clinical trial
A single intravenous infusion of DMT, a fast-acting psychedelic compound found in the Amazonian brew ayahuasca, significantly ...
—Researchers recently examined the impact of depressive symptoms, as measured by the 21-item Beck Depression Inventory, on adherence to therapy using correlation, network analysis, and linear ...
People taking DMT tended to experience significant relief from their depression for up to three months, the researchers found ...
A large review adds weight to an old idea: movement can help ease depression. Here’s how to think about exercise as part of treatment and recovery.
Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...
In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.
Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results